ArticleInternational journal of oncology2016

Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4⁺ T cell response against MC38 colon carcinoma.

Justyna Wojas-Turek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.